Caroline Popper, MD

Caroline Popper, MD the president and co-founder of Popper and Company has 15 years of hands-on biotech/life sciences operating experience. An internist and pathologist, she combines this perspective with that gained from managing a wide spectrum of life sciences businesses in diagnostics, devices and drug discovery. Her business management experience in both Fortune 500 and start-up settings and extensive track record creating strategic and business partnerships in the biotech arena is key to the perspective she provides to her clients.

In a 10-year career at Becton Dickinson (NYSE: BDX), Dr. Popper's global responsibilities included clinical affairs, marketing, strategy, and business development. She was the founding General Manager of BDGene; a start-up focused, with its partner Millennium Pharmaceuticals, on development of novel cancer diagnostics. From 2000 to 2002, she was the Chief Business Officer for MDS Proteomics, a drug discovery company with operations in the US, Canada and Europe.

Dr. Popper is currently a board member of ArrayExpress, Inc., a gene expression analysis company and Decision Biomarkers, a company with a novel protein biomarker array platform.

Dr. Popper received her MD from the University of the Witwatersrand (South Africa) and her MPH from Johns Hopkins University (Baltimore). She completed her residencies in Internal Medicine and in Pathology at Johns Hopkins.